Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of new clean-surface nanotechnology (CSN) therapies. The company is headquartered in Salt Lake City, Utah.
Data last updated: May 13, 2026 at 7:12 AM EDT
Get e-mail RSI alerts when Clene Inc. enters oversold or overbought territory. Free forever.
Add Alert